UroGen Pharma Ltd.
Pharmaceutical company · Ra'anana, Central District, Israel · Nasdaq: URGN
UroGen Pharma Ltd. is a pharmaceutical company headquartered in Ra'anana, Central District, Israel. Its shares trade on Nasdaq under the ticker URGN. The US FDA lists 1 medical device site registered to the company, with devices in gastroenterology and urology, clinical chemistry and general hospital. It has reported private securities offerings to the US SEC, most recently $120 million sold in a notice filed in 2023.
UroGen Pharma at a glance
What does UroGen Pharma do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $120 million sold (2023).
Where is UroGen Pharma located?
Headquarters: Ra'anana, Central District, Israel
- Ra'anana, Central DistrictUrogen Pharma Ltd. · FDA device site
Frequently asked questions about UroGen Pharma
Where is UroGen Pharma headquartered?
UroGen Pharma Ltd. is headquartered in Ra'anana, Central District, Israel.
What does UroGen Pharma do?
UroGen Pharma Ltd. is a pharmaceutical company. Its FDA-listed medical devices fall under gastroenterology and urology, clinical chemistry and general hospital. Its SEC industry classification is Pharmaceutical Preparations.
Is UroGen Pharma a public company?
Yes. UroGen Pharma Ltd. trades on Nasdaq under the ticker URGN.
Similar companies
- MediWound Ltd.Yavné, Central District, Israel
- RedHill Biopharma Ltd.Tel Aviv, Israel
- Chemomab Therapeutics Ltd.Tel Aviv, Israel
- Nasus Pharma LtdTel Aviv, Israel
- Can-Fite BioPharma Ltd.Ramat Gan, Tel Aviv, Israel
- NeuroSense Therapeutics Ltd.Herzliya, Tel Aviv, Israel
- BioLineRx Ltd.Modi‘in Makkabbim Re‘ut, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.